Manufacturing capability

The full range, stated form by form.

Twelve categories covering every major pharmaceutical dosage form and the development services around them. Each item is marked according to whether it runs in-house or through our qualified manufacturing network.

In-houseQualified network Tier assignment is indicative in this draft and confirmed against the specific product and market at enquiry stage.
How to read this

Breadth is a supply-chain statement, not a plant statement.

No pharmaceutical company manufactures every one of these forms within its own walls. We describe our capability as what it is — part owned, part networked — which is also why we are able to tell a partner, before commitment, which facility would run their product and what its regulatory standing is.

Therapeutic coverage

Thirty-nine segments, acute and chronic.

Talk to us

Tell us the molecule and the market.

Distribution, contract manufacturing and licensing all reach the same desk. Write to us with the product and the territory, and the first reply will be substantive.

Quality & regulatoryquality@anzalp.com
Pharmacovigilancepv@anzalp.com
partnering@anzalp.com
Distribution · Contract development & manufacturing · Licensing
India37 Rambali, Fort Industrial Estate, Indore, Madhya Pradesh 452006
United States16192 Coastal Highway, Lewes, Delaware 19958, County of Sussex